U.S., June 30 -- ClinicalTrials.gov registry received information related to the study (NCT07673081) titled 'Real-World Effectiveness of RSV Vaccines Among Adults Using Target Trial Emulation in Epic Cosmos' on June 22.
Brief Summary: Among non-pregnant adults observed in Epic Cosmos since August 2023 who are eligible for RSV vaccination, what is the effectiveness of ABRYSVO(R) (RSVpreF), compared with unvaccinated individuals, in preventing RSV-related and all-cause acute respiratory illness (ARI), lower respiratory tract disease (LRTD), and other outcomes of interest, within a target trial emulation (TTE) framework
Study Start Date: June 20
Study Type: OBSERVATIONAL
Condition:
Respiratory Syncytial Virus (RSV)
Recruitment Status: NO...